Quadrature Capital LTD Royalty Pharma PLC Transaction History

Quadrature Capital LTD

  • $4.41 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Mar 25, 2024
BUY
$29.6 - $36.56 $714,336 - $882,302
24,133 New
24,133 $742 Million
Q1 2022

Apr 08, 2024
BUY
$37.46 - $42.44 $273,383 - $309,727
7,298 New
7,298 $284 Million
Q2 2021

Apr 09, 2024
BUY
$39.85 - $46.63 $306,845 - $359,051
7,700 New
7,700 $316 Million

Others Institutions Holding RPRX

# of Institutions
415
Shares Held
282M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $13.9B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email